Transcriptome-based synthetic lethality predictions to improve targeted therapy/immunotherapy treatment prioritization in non-metastatic breast cancer: BC-SELECT.

Kim Y, Nagy M, Pollard R, Rajagopal PS

Open source

DOI
10.1158/2767-9764.crc-26-0401
Published
2026 Sep 3
Container
Cancer research communications
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/2767-9764.crc-26-0401,
  title = {Transcriptome-based synthetic lethality predictions to improve targeted therapy/immunotherapy treatment prioritization in non-metastatic breast cancer: BC-SELECT.},
  author = {Kim Y and Nagy M and Pollard R and Rajagopal PS},
  year = {2026},
  journal = {Cancer research communications},
  doi = {10.1158/2767-9764.crc-26-0401},
  url = {https://doi.org/10.1158/2767-9764.crc-26-0401}
}

RIS

TY  - JOUR
TI  - Transcriptome-based synthetic lethality predictions to improve targeted therapy/immunotherapy treatment prioritization in non-metastatic breast cancer: BC-SELECT.
AU  - Kim Y
AU  - Nagy M
AU  - Pollard R
AU  - Rajagopal PS
PY  - 2026
JO  - Cancer research communications
DO  - 10.1158/2767-9764.crc-26-0401
UR  - https://doi.org/10.1158/2767-9764.crc-26-0401
ER  - 

APA

Y, K., M, N., R, P., & PS, R. (2026). Transcriptome-based synthetic lethality predictions to improve targeted therapy/immunotherapy treatment prioritization in non-metastatic breast cancer: BC-SELECT.. Cancer research communications. https://doi.org/10.1158/2767-9764.crc-26-0401

Source records